Cargando…

Addition of a Viral Immunomodulatory Domain to Etanercept Generates a Bifunctional Chemokine and TNF Inhibitor

The inhibition of tumor necrosis factor (TNF) through the use of either antibodies or soluble receptors is a highly effective strategy for the clinical control of chronic inflammatory conditions such as rheumatoid arthritis. Different viruses have similarly exploited this concept by expressing a set...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alejo, Alí, Sánchez, Carolina, Amu, Sylvie, Fallon, Padraic G., Alcamí, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020083/ https://www.ncbi.nlm.nih.gov/pubmed/31877657 http://dx.doi.org/10.3390/jcm9010025

Ejemplares similares

Enhancement of Chemokine Function as an Immunomodulatory Strategy Employed by Human Herpesviruses
por: Viejo-Borbolla, Abel, et al.
Publicado: (2012)

Chemokines cooperate with TNF to provide protective anti-viral immunity and to enhance inflammation
por: Alejo, Alí, et al.
Publicado: (2018)

An orphan viral TNF receptor superfamily member identified in lymphocystis disease virus
por: Pontejo, Sergio M, et al.
Publicado: (2013)

Composition of the Schistosoma mansoni worm secretome: Identification of immune modulatory Cyclophilin A
por: Floudas, Achilleas, et al.
Publicado: (2017)

Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity
por: Smith, Philip, et al.
Publicado: (2005)

Immunomodulatory Therapeutic Strategies in Stroke
por: Malone, Kyle, et al.
Publicado: (2019)

Inhibition of Type 1 Cytokine–mediated Inflammation by a Soluble CD30 Homologue Encoded by Ectromelia (Mousepox) Virus
por: Saraiva, Margarida, et al.
Publicado: (2002)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
por: Henry, Alistair I, et al.
Publicado: (2011)

Immunomodulatory biomaterials on chemokine signaling in wound healing
por: Apte, Anisha, et al.
Publicado: (2023)

Influence of TNFα–308 and T676G TNF-RII polymorphism on response to etanercept and posibility to discontinue tretment
por: Vojinovic, J, et al.
Publicado: (2011)

Therapy with soluble TNF receptor (etanercept) induces apoptosis in rheumatoid arthritis (RA) synovium
por: Catrina, AI, et al.
Publicado: (2003)

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
por: Neovius, M, et al.
Publicado: (2015)

Effects of Etanercept on TNF-α Inhibition in Rats with Adenine-Induced Chronic Kidney Disease
por: Mendieta-Condado, Edgar, et al.
Publicado: (2022)

Development of tartaric esters as bifunctional additives of methanol-gasoline
por: Zhang, Jie, et al.
Publicado: (2014)

Use of anti-TNF Etanercept in paediatric patients with autoimmune disease and ocular involvement: the Parma experience
por: Rossi, M, et al.
Publicado: (2008)

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
por: Duret, Pierre-Marie, et al.
Publicado: (2020)

New insights into the immunomodulatory properties of poxvirus cytokine decoy receptors at the cell surface
por: Hernaez, Bruno, et al.
Publicado: (2018)

Etanercept biosimilars
por: Azevedo, Valderilio F., et al.
Publicado: (2014)

Viral Chemokine Receptors
por: Murphy, Philip M.
Publicado: (2015)

Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment
por: Kreiner, Frederik Flindt, et al.
Publicado: (2012)

TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis
por: Liu, Jing, et al.
Publicado: (2016)

Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb(-/-) lupus model
por: Sakunrangsit, Nithidol, et al.
Publicado: (2021)

Continuous Use of Etanercept During Pregnancy Does Not Affect TNF-Alpha Levels in Umbilical Cord Blood
por: Nishide, Masayuki, et al.
Publicado: (2022)

Bifunctional hairy silica nanoparticles as high-performance additives for lubricant
por: Sui, Tianyi, et al.
Publicado: (2016)

The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine
por: Beck, Tyler C., et al.
Publicado: (2020)

The TNF-α antagonist etanercept reverses age-related decreases in colonic SERT expression and faecal output in mice
por: Patel, Bhavik Anil, et al.
Publicado: (2017)

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases
por: Kiltz, Uta, et al.
Publicado: (2022)

Treatment of LADA With Etanercept
por: Montes, Vince N., et al.
Publicado: (2012)

Etanercept-associated myelitis
por: Finke, Carsten, et al.
Publicado: (2015)

Etanercept-associated Nephropathy
por: Ammar, Awais, et al.
Publicado: (2019)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
por: Felis-Giemza, Anna, et al.
Publicado: (2019)

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains
por: Levin, Steven D., et al.
Publicado: (2020)

Generation of αGal-enhanced bifunctional tumor vaccine
por: He, Jian, et al.
Publicado: (2022)

Viral Anticytokine Strategies
por: Alcami, Antonio
Publicado: (2016)

Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer
por: Mukaida, Naofumi, et al.
Publicado: (2011)

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
por: Hirabara, Shinya, et al.
Publicado: (2014)

Etanercept Attenuates Traumatic Brain Injury in Rats by Reducing Brain TNF-α Contents and by Stimulating Newly Formed Neurogenesis
por: Cheong, Chong-Un, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f4j3hgb7ciq53je1k3qu4ka40o